Connection

Federico Diotallevi to Risk Assessment

Back to Details
This is a "connection" page, showing publications Federico Diotallevi has written about Risk Assessment.
Federico Diotallevi
Connection Strength
0.010
Risk Assessment
  1. Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy. Dermatol Ther. 2020 Nov; 33(6):e14256.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.